12 Recruiting Solid Tumors Phase 1 / Phase 2 Clinical Trials
Active phase 1 / phase 2 studies for solid tumors enrolling across the USA. Verify eligibility and contact site coordinators.
All Solid Tumors studiesPhase 1 / Phase 2 Studies for Solid Tumors
Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)
📍 University of California - Los Angeles - 300208353 — Santa Monica, California
View Study & Checklist ➔A Study to Evaluate INCB177054 in Participants With Select Advanced or Metastatic Solid Tumors
📍 The Angeles Clinic and Research Institute — Los Angeles, California
View Study & Checklist ➔GEN1046 Safety Trial in Patients With Malignant Solid Tumors
📍 Mayo Clinic — Phoenix, Arizona
View Study & Checklist ➔Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔Dose Escalation Study of a PD1-LAG3 Bispecific Antibody in Patients With Advanced and/or Metastatic Solid Tumors
📍 Rigshospitalet — København Ø,
View Study & Checklist ➔Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options
📍 University of California San Diego — La Jolla, California
View Study & Checklist ➔JAB-2485 Activity in Adult Patients With Advanced Solid Tumors
📍 Henry Ford Health System — Detroit, Michigan
View Study & Checklist ➔JAB-30355 in Patients With Advanced Solid Tumors Harboring TP53 Y220C Mutation
📍 Research Site — Denver, Colorado
View Study & Checklist ➔ABL103 in Combination With Pembrolizumab, With or Without Taxane in Advanced or Metastatic Solid Tumors
📍 UH Cleveland Medical Center — Cleveland, Ohio
View Study & Checklist ➔S-531011 as Monotherapy and in Combination With an Immune Checkpoint Inhibitor in Advanced or Metastatic Solid Tumors
📍 Angeles Clinic and Research Center — Los Angeles, California
View Study & Checklist ➔A Study of ZL-1310 in Participants With Selected Solid Tumors
📍 University of California San Francisco/Helen Diller Family Comprehensive Cancer Center — San Francisco, California
View Study & Checklist ➔Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
📍 City of Hope — Duarte, California
View Study & Checklist ➔